That being said, I can see some applications to using ML to analyze the results of CRISPR/Cas9 screens or better predict functional editing sites - but that's not exactly exclusive to Cas9.
ML provides predictive capabilities over large fugly datasets. CRISPR gives us the ability to test those predictions. These are both essentially commodity technologies at this point and not everyone is going to take a disciplined approach to experimentation.
EDIT: And don't forget Kubernetes.
https://www.genscript.com/crispr-services.html
https://canopybiosciences.com/custom-cell-line-engineering-2...
https://www.reprocell.com/gene-editing-services-i174
etc. etc.
This guy lifestreams some really interesting work - https://www.youtube.com/user/TheChemlife/videos
The conclusion was that the data would be far too sparse for the algorithm to really learn anything.
I've been seeing similar comments a lot lately, and I don't understand why. As someone with a background in ML that is now studying biochemistry I'd be the first person to jump at something like that, but I'm just not seeing any big ML potential that directly has to do with CRISPR.
Is it just two hyped technologies being thrown in a pot? Is there something I'm missing?